On March 15, 2024, FDA published a white paper titled “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together” (the AI White Paper) on the use of artificial ...
The success of Boston Scientific's Taxus drug-eluting stent helped boost combination products' popularity. However, the regulatory requirements for such products are strict. Who Will Be the Lead ...
“Designing treatments unique to individual patients has always been the promised goal of personalized medicine. After 25 years the FDA has, for the first time, outlined a framework to facilitate these ...
October 1996 guidelines on the distribution of journal reprints and medical texts by drug companies issued by the U.S. Food and Drug Administration (FDA): http://www.fda.gov/cder/guidance/fr8oct96.htm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results